AbbVie vs Intel
Comparaison de la capitalisation boursière au fil du temps
AbbVie
$461.3B
Rang #27
Intel
$604.9B
Rang #22
Capitalisation boursière au fil du temps
Moments clés
- AbbVie a dépassé Intel avant 2022
- Intel a dépassé AbbVie avant 2026
Comparaison année par année
| Année | AbbVie | Intel | Leader |
|---|---|---|---|
| 2026 | $461.3B | $604.9B | Intel |
| 2025 | $397.2B | $185.5B | AbbVie |
| 2024 | $298.5B | $100.8B | AbbVie |
| 2023 | $251.1B | $249.2B | AbbVie |
| 2022 | $251.7B | $128.1B | AbbVie |
| 2021 | $203.0B | $240.1B | Intel |
| 2020 | $153.3B | $226.4B | Intel |
| 2019 | $120.0B | $265.3B | Intel |
| 2018 | $118.3B | $203.0B | Intel |
| 2017 | $119.4B | $194.8B | Intel |
| 2016 | $74.6B | $148.8B | Intel |
| 2015 | $67.9B | $136.8B | Intel |
| 2014 | $72.7B | $139.9B | Intel |
| 2013 | $56.8B | $97.0B | Intel |